Arovella Therapeutics Seeks ASX Share Quotation
Company Announcements

Arovella Therapeutics Seeks ASX Share Quotation

Arovella Therapeutics Limited (AU:ALA) has released an update.

Arovella Therapeutics Limited has announced an application for the quotation of new securities on the ASX, with 67,568 ordinary fully paid shares set to be quoted. The application, pertaining to shares issued under an employee incentive scheme, reflects the company’s latest move in the financial markets as of September 19, 2024.

For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskArovella Therapeutics Expands with New Share Issue and Cancer Therapies
TipRanks Australian Auto-Generated NewsdeskArovella Therapeutics Lists New Securities on ASX
TipRanks Australian Auto-Generated NewsdeskArovella Therapeutics Unveils Promising Cancer Therapy Platform
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App